• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金鸡纳生物碱与TRAF6的RING结构域竞争性结合引发的体外和体内癌细胞凋亡。

In vitro and in vivo cancer cell apoptosis triggered by competitive binding of Cinchona alkaloids to the RING domain of TRAF6.

作者信息

Qi Yonghao, Zhao Xuan, Chen Jiaying, Pradipta Ambara R, Wei Jing, Ruan Haihua, Zhou Lijun, Hsung Richard P, Tanaka Katsunori

机构信息

a Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology , Tianjin University , Tianjin , P.R. China.

b Biofunctional Synthetic Chemistry Laboratory , RIKEN , Wako, Saitama , Japan.

出版信息

Biosci Biotechnol Biochem. 2019 Jun;83(6):1011-1026. doi: 10.1080/09168451.2018.1559030. Epub 2018 Dec 20.

DOI:10.1080/09168451.2018.1559030
PMID:31074699
Abstract

TRAF6 is highly expressed in many tumors and plays an important role in the immune system. The aim of this study is to confirm anti-tumor activities of all naturally occurring Cinchona alkaloids that have been screened using computational docking program, and to validate the accuracy and specificity of the RING domain of TRAF6 as a potential anti-tumor target, and to explore their effect on the immune system. Results reported herein would demonstrate that Cinchona alkaloids could induce apoptosis in HeLa cells, inhibit the ubiquitination and phosphorylation of both AKT and TAK1, and up-regulate the ratio of Bax/Bcl-2. In addition, these compounds could induce apoptosis in vivo, and increase the secretion of TNF-α, IFN-γ, and IgG, while not significantly impacting the ratio of CD4T/CD8T. These investigations suggest that the RING domain of TRAF6 could serve as a de novo biological target for therapeutic treatment in cancers.

摘要

TRAF6在许多肿瘤中高表达,并在免疫系统中发挥重要作用。本研究的目的是确认使用计算对接程序筛选出的所有天然金鸡纳生物碱的抗肿瘤活性,验证TRAF6的RING结构域作为潜在抗肿瘤靶点的准确性和特异性,并探索它们对免疫系统的影响。本文报道的结果将证明金鸡纳生物碱可诱导HeLa细胞凋亡,抑制AKT和TAK1的泛素化和磷酸化,并上调Bax/Bcl-2的比率。此外,这些化合物可在体内诱导凋亡,并增加TNF-α、IFN-γ和IgG的分泌,同时对CD4T/CD8T的比率没有显著影响。这些研究表明,TRAF6的RING结构域可作为癌症治疗的全新生物学靶点。

相似文献

1
In vitro and in vivo cancer cell apoptosis triggered by competitive binding of Cinchona alkaloids to the RING domain of TRAF6.金鸡纳生物碱与TRAF6的RING结构域竞争性结合引发的体外和体内癌细胞凋亡。
Biosci Biotechnol Biochem. 2019 Jun;83(6):1011-1026. doi: 10.1080/09168451.2018.1559030. Epub 2018 Dec 20.
2
Cinchonine induces apoptosis of HeLa and A549 cells through targeting TRAF6.辛可宁通过靶向肿瘤坏死因子受体相关因子6(TRAF6)诱导人宫颈癌HeLa细胞和人肺癌A549细胞凋亡。
J Exp Clin Cancer Res. 2017 Feb 23;36(1):35. doi: 10.1186/s13046-017-0502-8.
3
N6-Isopentenyladenosine promoted HeLa cell apoptosis through inhibitions of AKT and transforming growth factor β-activated kinase 1 activation.N6-异戊烯基腺苷通过抑制AKT和转化生长因子β激活激酶1的激活促进HeLa细胞凋亡。
Tumour Biol. 2017 Mar;39(3):1010428317695966. doi: 10.1177/1010428317695966.
4
Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.表没食子儿茶素-3-没食子酸酯(EGCG)通过靶向TRAF6活性抑制黑色素瘤细胞的生长和转移。
Oncotarget. 2016 Nov 29;7(48):79557-79571. doi: 10.18632/oncotarget.12836.
5
Suppression of tumor cell proliferation by quinine via the inhibition of the tumor necrosis factor receptor‑associated factor 6‑AKT interaction.奎宁通过抑制肿瘤坏死因子受体相关因子6与AKT的相互作用来抑制肿瘤细胞增殖。
Mol Med Rep. 2016 Sep;14(3):2171-9. doi: 10.3892/mmr.2016.5492. Epub 2016 Jul 11.
6
Mechanism of ubiquitin transfer promoted by TRAF6.TRAF6 促进泛素转移的机制。
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1783-1788. doi: 10.1073/pnas.1721788115. Epub 2018 Feb 5.
7
Tumor necrosis factor receptor-associated factor 6 contributes to malignant behavior of human cancers through promoting AKT ubiquitination and phosphorylation.肿瘤坏死因子受体相关因子 6 通过促进 AKT 的泛素化和磷酸化促进人类癌症的恶性行为。
Cancer Sci. 2019 Jun;110(6):1909-1920. doi: 10.1111/cas.14012. Epub 2019 Apr 29.
8
Oligomerization-primed coiled-coil domain interaction with Ubc13 confers processivity to TRAF6 ubiquitin ligase activity.寡聚引发的卷曲螺旋结构域与Ubc13的相互作用赋予TRAF6泛素连接酶活性持续性。
Nat Commun. 2017 Oct 9;8(1):814. doi: 10.1038/s41467-017-01290-0.
9
TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.白藜芦醇通过抑制 TRAF6 来抑制 TLR4 介导的 NF-κB 激活。
J Nutr Biochem. 2013 May;24(5):819-23. doi: 10.1016/j.jnutbio.2012.04.017. Epub 2012 Aug 24.
10
Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.磷酸肌醇依赖性激酶-1通过中断Toll样受体4信号通路中TAK1-TAB2复合物的形成来抑制TRAF6泛素化。
Cell Signal. 2015 Dec;27(12):2524-33. doi: 10.1016/j.cellsig.2015.09.018. Epub 2015 Sep 30.

引用本文的文献

1
The up-regulated expression level of deubiquitinating enzyme USP46 induces the apoptosis of A549 cells by TRAF6.去泛素化酶USP46表达水平上调通过TRAF6诱导A549细胞凋亡。
Invest New Drugs. 2025 Apr;43(2):328-336. doi: 10.1007/s10637-025-01532-9. Epub 2025 Apr 23.
2
Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors.靶向SMAD依赖信号传导:上皮性和间叶性实体瘤的相关考量
Pharmaceuticals (Basel). 2024 Mar 1;17(3):326. doi: 10.3390/ph17030326.
3
Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis.
氢化奎尼丁通过抑制细胞周期和刺激细胞凋亡,在乳腺癌和卵巢癌细胞中显示出显著的抗癌活性。
Turk J Biol. 2023 Jan 11;47(1):44-60. doi: 10.55730/1300-0152.2640. eCollection 2023.
4
E3 ubiquitin ligase on the biological properties of hematopoietic stem cell.E3 泛素连接酶对造血干细胞生物学特性的影响。
J Mol Med (Berl). 2023 May;101(5):543-556. doi: 10.1007/s00109-023-02315-6. Epub 2023 Apr 21.
5
Benzoyl-xanthone derivative induces apoptosis in MCF-7 cells by binding TRAF6.苯甲酰氧杂蒽衍生物通过结合TRAF6诱导MCF-7细胞凋亡。
Exp Ther Med. 2022 Feb;23(2):181. doi: 10.3892/etm.2021.11104. Epub 2021 Dec 30.
6
The relationship between TRAF6 and tumors.肿瘤坏死因子受体相关因子6(TRAF6)与肿瘤的关系。
Cancer Cell Int. 2020 Sep 3;20:429. doi: 10.1186/s12935-020-01517-z. eCollection 2020.